The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT- and rTg(P301L)4510 mouse models of Alzheimer's disease.

Saved in:
Bibliographic Details
Title: The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT- and rTg(P301L)4510 mouse models of Alzheimer's disease.
Authors: Jimenez H; Northwell Health The Feinstein Institutes for Medical Research Manhasset New York USA., Adrien L; Northwell Health The Feinstein Institutes for Medical Research Manhasset New York USA., Wolin A; Northwell Health The Feinstein Institutes for Medical Research Manhasset New York USA., Eun J; Northwell Health The Feinstein Institutes for Medical Research Manhasset New York USA., Chang EH; Northwell Health The Feinstein Institutes for Medical Research Manhasset New York USA., Burstein ES; ACADIA Pharmaceuticals San Diego California USA., Gomar J; Northwell Health The Feinstein Institutes for Medical Research Manhasset New York USA., Davies P; Northwell Health The Feinstein Institutes for Medical Research Manhasset New York USA., Koppel J; Northwell Health The Feinstein Institutes for Medical Research Manhasset New York USA.
Source: Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2022 Feb 01; Vol. 8 (1), pp. e12247. Date of Electronic Publication: 2022 Feb 01 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101650118 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-8737 (Electronic) Linking ISSN: 23528737 NLM ISO Abbreviation: Alzheimers Dement (N Y) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first